• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人腺病毒 4 型 a 样株的编码 DsRed 的复制型载体的鉴定。

Characterization of a replication-competent vector encoding DsRed based on a human adenovirus type 4 a-like strain.

机构信息

State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.

State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.

出版信息

Virus Res. 2019 Sep;270:197662. doi: 10.1016/j.virusres.2019.197662. Epub 2019 Jul 10.

DOI:10.1016/j.virusres.2019.197662
PMID:31301331
Abstract

Human adenovirus type 4 (HAdV4) is an etiological agent of acute respiratory disease (ARD) in pediatric and adult patients. HAdV4 strains can be divided into two major genomic clusters, namely prototype (p)-like viruses and a-like viruses. Here, the complete genome sequence of HAdV4 strain GZ01, isolated from a child with ARD in southern China, is first reported and analyzed. This strain was determined to be of the 4a1 genome-type based on in silico restriction profiles. Then, a replication-competent rAd4DsRed virus, containing the HAdV4 GZ01 infectious genome and expressing the reporter molecule DsRed, was generated and characterized. Recombinant rAd4DsRed can infect AD293, hamster, and mouse cells in which DsRed protein was expressed. No changes in antigenicity and genome replication were detected for rAd4DsRed and wild-type HAdV4. Mice immunized with rAd4DsRed was elicited a marked antibody response to DsRed. A rapid method of testing neutralizing antibodies against HAdV3 and HAdV4 was also established using a mixture of rAd4DsRed and rAd3EGFP. Our results provide the foundation to develop HAdV4 vaccines, potential vector platforms for vaccine and gene therapy, and rapid methods for serological and antiviral screening.

摘要

人腺病毒 4 型(HAdV4)是儿科和成年患者急性呼吸道疾病(ARD)的病因。HAdV4 株可分为两个主要基因组群,即原型(p)样病毒和 a 样病毒。本文首次报道并分析了从中国南方一名 ARD 患儿中分离到的 HAdV4 株 GZ01 的全基因组序列。该株基于计算机模拟的限制图谱被确定为 4a1 基因组型。然后,生成并表征了含有 HAdV4 GZ01 感染性基因组并表达报告分子 DsRed 的复制型 rAd4DsRed 病毒。重组 rAd4DsRed 可感染 AD293、仓鼠和表达 DsRed 蛋白的小鼠细胞。rAd4DsRed 和野生型 HAdV4 的抗原性和基因组复制均未发生变化。用 rAd4DsRed 免疫的小鼠对 DsRed 产生了明显的抗体反应。还建立了一种使用 rAd4DsRed 和 rAd3EGFP 混合物检测针对 HAdV3 和 HAdV4 的中和抗体的快速方法。我们的研究结果为开发 HAdV4 疫苗、疫苗和基因治疗的潜在载体平台以及血清学和抗病毒筛选的快速方法提供了基础。

相似文献

1
Characterization of a replication-competent vector encoding DsRed based on a human adenovirus type 4 a-like strain.基于人腺病毒 4 型 a 样株的编码 DsRed 的复制型载体的鉴定。
Virus Res. 2019 Sep;270:197662. doi: 10.1016/j.virusres.2019.197662. Epub 2019 Jul 10.
2
Oral Vaccination with Replication-Competent Adenovirus in Mice Reveals Dissemination of the Viral Vaccine beyond the Gastrointestinal Tract.口服复制型腺病毒疫苗在小鼠体内的接种实验揭示了病毒疫苗在胃肠道以外的传播。
J Virol. 2019 Jun 14;93(13). doi: 10.1128/JVI.00237-19. Print 2019 Jul 1.
3
A tetravalent vaccine comprising hexon-chimeric adenoviruses elicits balanced protective immunity against human adenovirus types 3, 7, 14 and 55.一种包含六邻体嵌合腺病毒的四价疫苗能引发针对人腺病毒 3、7、14 和 55 型的平衡保护免疫。
Antiviral Res. 2018 Jun;154:17-25. doi: 10.1016/j.antiviral.2018.04.001. Epub 2018 Apr 4.
4
Laboratory-Scale Production of Replication-Deficient Adenovirus Vectored Vaccines.
Methods Mol Biol. 2016;1349:121-35. doi: 10.1007/978-1-4939-3008-1_8.
5
Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: "Adenovirus Vaccine Within an Adenovirus Vector".新型重组减毒和复制缺陷型人腺病毒 3 候选疫苗的构建与鉴定:“腺病毒载体中的腺病毒疫苗”。
Virol Sin. 2021 Jun;36(3):354-364. doi: 10.1007/s12250-020-00234-1. Epub 2020 May 26.
6
Seroprevalence of Neutralizing Antibodies to Human Adenovirus Type 4 and 7 in Healthy Populations From Southern China.中国南方健康人群中针对4型和7型人腺病毒的中和抗体血清流行率
Front Microbiol. 2018 Dec 10;9:3040. doi: 10.3389/fmicb.2018.03040. eCollection 2018.
7
Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector.构建并表征一种具有复制能力的基于3型人腺病毒的载体,作为一种活疫苗候选物和病毒递送载体。
Vaccine. 2009 Feb 18;27(8):1145-53. doi: 10.1016/j.vaccine.2008.12.039. Epub 2009 Jan 13.
8
Rapid Construction of a Replication-Competent Infectious Clone of Human Adenovirus Type 14 by Gibson Assembly.利用 Gibson 组装技术快速构建具有复制能力的人腺病毒 14 型感染性克隆。
Viruses. 2018 Oct 18;10(10):568. doi: 10.3390/v10100568.
9
Neutralizing epitopes mapping of human adenovirus type 14 hexon.人14型腺病毒六邻体的中和表位定位
Vaccine. 2015 Nov 27;33(48):6659-65. doi: 10.1016/j.vaccine.2015.10.117. Epub 2015 Nov 3.
10
Adenovirus type 4 and 7 vaccination or adenovirus type 4 respiratory infection elicits minimal cross-reactive antibody responses to nonhuman adenovirus vaccine vectors.4型和7型腺病毒疫苗接种或4型腺病毒呼吸道感染引发的针对非人腺病毒疫苗载体的交叉反应性抗体反应极小。
Clin Vaccine Immunol. 2014 May;21(5):783-6. doi: 10.1128/CVI.00011-14. Epub 2014 Mar 12.

引用本文的文献

1
Human adenovirus type 4 (HAdV-4) associated acute respiratory tract infection in children & genetic characteristics of HAdV-4 in China: a prospective multicenter study.中国儿童人腺病毒 4 型(HAdV-4)相关急性呼吸道感染:一项前瞻性多中心研究。
BMC Infect Dis. 2024 Sep 9;24(1):936. doi: 10.1186/s12879-024-09835-7.
2
Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases.病毒载体疫苗:在人类疾病中的设计、开发、预防和治疗应用。
Signal Transduct Target Ther. 2023 Apr 7;8(1):149. doi: 10.1038/s41392-023-01408-5.
3
Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential.
重组水疱性口炎病毒抗尼帕病毒疫苗具有良好的安全性:用于评估具有神经嗜性潜力的活疫苗的模型。
PLoS Pathog. 2022 Jun 27;18(6):e1010658. doi: 10.1371/journal.ppat.1010658. eCollection 2022 Jun.
4
Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated Terminal Resolution.通过CRISPR/Cas介导的末端切割拯救重组腺病毒
Front Microbiol. 2022 Mar 18;13:854690. doi: 10.3389/fmicb.2022.854690. eCollection 2022.
5
Seroprevalence of Neutralizing Antibodies against Six Human Adenovirus Types Indicates the Low Level of Herd Immunity in Young Children from Guangzhou, China.中国广州儿童针对六种人腺病毒血清中和抗体阳性率表明其群体免疫力较低。
Virol Sin. 2021 Jun;36(3):373-381. doi: 10.1007/s12250-020-00307-1. Epub 2020 Nov 9.
6
Outbreaks of Adenovirus-associated Respiratory Illness on 5 College Campuses in the United States, 2018-2019.美国 5 所大学校园 2018-2019 年腺病毒相关呼吸道疾病暴发。
Clin Infect Dis. 2021 Jun 1;72(11):1992-1999. doi: 10.1093/cid/ciaa465.